CASI Pharma (CASI) Misses Q3 EPS by 67c

CASI Pharma (NASDAQ: CASI) reported Q3 EPS of ($0.67). Revenue for the quarter came in at $3.07 million.

For earnings history and earnings-related data on CASI Pharma (CASI) click here.

You May Also Be Interested In

• S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
• ICICI Securities Starts Amagi Media Labs (AMAGI:IN) at Buy (1)
• Samsara Inc (IOT) PT Raised to $55 at BNP Paribas Exane